"May bypass many of these problems".
Let's face it, you need to prove efficacy with the cells first before the 'problems' require solving. Horse before the cart. And, it 'may' not.
I'm watching the OA P3 trial. I also think the FDA hold the keys to MSC's success. I wait and watch.
CYP is acting as if they have already done a successful P3 with the FDA, or it's a given they will nail it. It doesn't work that way.
FDA or bust, I reckon. When was the GVHD P2 STARTING again?
"May bypass many of these problems".Let's face it, you need to...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.015(9.68%) |
Mkt cap ! $38.41M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 17.0¢ | 15.5¢ | $47.10K | 289.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 23813 | 3 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |